NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

NKG2D-DAP10 triggers human NK cell–mediated killing via a Syk-independent regulatory pathway

Published:2003-05-11 Issue:6 Volume:4 Page:557-564
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Billadeau Daniel D,Upshaw Jadee L,Schoon Renee A,Dick Christopher J,Leibson Paul J

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni929.pdf

Reference39 articles.

1. Moretta, A. et al. Activating receptors and coreceptors involved in human natural killer cell–mediated cytolysis. Annu. Rev. Immunol. 19, 197–223 (2001).

2. Cerwenka, A. & Lanier, L.L. Natural killer cells, viruses and cancer. Nat. Rev. Immunol. 1, 41–49 (2001).

3. Colucci, F., DiSanto, J.P. & Leibson, P.J. Natural killer cell activation in mice and men: different triggers for similar weapons? Nat. Immunol. 3, 807–813 (2002).

4. Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 272–729 (1999).

5. Cerwenka, A. et al. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721–727 (2000).

Cited by 312 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The primary sclerosing cholangitis and ulcerative colitis colonic mucosa defined through paired microbial and single-cell RNA sequencing;2024-08-12

2. Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective;Biomarker Research;2024-07-17

3. Beyond CAR T cells: exploring alternative cell sources for CAR-like cellular therapies;Biological Chemistry;2024-05-21

4. Challenges and Recent Advances in NK-Mediated Adoptive Cell Therapies against Cancer;Advances in Cancer Immunotherapy [Working Title];2024-05-06

5. Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells;Cancer Immunology, Immunotherapy;2024-01-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3